Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hematologic Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Barrett Esophagus 1

Interventions

pembrolizumab 46Cisplatin 31Carboplatin 20Cetuximab 16Nivolumab 15Paclitaxel 14Radiotherapy, Intensity-Modulated 12Radiotherapy 10Docetaxel 10Fluorouracil 9Platinum 8durvalumab 7Taxes 71,2-diaminocyclohexaneplatinum II citrate 7Radiation 6tislelizumab 5Magnetic Resonance Spectroscopy 5Albumin-Bound Paclitaxel 5cemiplimab 4avelumab 4Specimen Handling 4Radiosurgery 4Drug Therapy 4Biopsy 4130-nm albumin-bound paclitaxel 4tremelimumab 3palbociclib 3olaparib 3dostarlimab 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Squamous Cell Carcinoma of Head and Neck × Itraconazole × Clear all
NCT06084481 2026-01-20

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

AbbVie

Phase 1 Active not recruiting
302 enrolled
BreastGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡